Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2011
09/20/2011CA2425193C Oligonucleotide - facilitated coalescence
09/20/2011CA2400562C Hybrid expression of neisserial proteins
09/20/2011CA2399733C Nucleic acid detection methods using universal priming
09/20/2011CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
09/20/2011CA2376485C Recombinant anti-cd40 antibody and uses thereof
09/20/2011CA2369848C Human endogenous retrovirus in breast cancer
09/20/2011CA2360758C 1-deoxy-d-xylulose-5-phosphate reductoisomerases, and methods of use
09/20/2011CA2356009C Vascular endothelial growth factor-x
09/20/2011CA2347248C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
09/20/2011CA2337100C Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same
09/20/2011CA2333432C Methods and means to modulate programmed cell death in eukaryotic cells
09/20/2011CA2331258C Enhancement of b cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and ebv gp350/220
09/20/2011CA2329137C Novel tumor antigen useful in diagnosis and therapy of prostrate and colon cancer
09/20/2011CA2319784C Methods for predicting pregnancy outcome in a subject by hcg assay
09/20/2011CA2319700C Methods of identifying genes involved in enhanced wound healing in mice
09/20/2011CA2262403C Biomarkers and targets for diagnosis, prognosis and management of prostate disease
09/20/2011CA2259144C Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1
09/20/2011CA2217522C Isolated frpb nucleic acid molecule and vaccine
09/20/2011CA2183542C Methods and compositions for stimulating bone cells
09/20/2011CA2115828C Calcium receptor active molecules
09/15/2011WO2011113050A1 Method and composition for alveolar epithelial cell-specific nucleic acid nuclear import
09/15/2011WO2011113030A2 Human cancer micro-rna expression profiles predictive of chemo-response
09/15/2011WO2011113027A2 Npp1 fusion proteins
09/15/2011WO2011113015A2 Antisense modulation of nuclear hormone receptors
09/15/2011WO2011113004A2 Markers associated with alzheimer's disease
09/15/2011WO2011112980A2 Innate immunity markers of cancer
09/15/2011WO2011112955A1 Bluetongue virus recombinant vaccines and uses thereof
09/15/2011WO2011112954A1 Inhibition of p21 and use thereof for inducing tissue regeneration
09/15/2011WO2011112945A2 Foot and mouth disease virus recombinant vaccines and uses thereof
09/15/2011WO2011112935A2 Antibody fusion proteins with disrupted heparin-binding activity
09/15/2011WO2011112915A2 Methods and compositions containing fc fusiong proteins for enhancing immune responses
09/15/2011WO2011112903A2 Quantitative rt-pcr detection for genes involved in epithelial mesenchymal transition in peripheral blood of breast cancer patients
09/15/2011WO2011112902A2 Nonviral gene delivery vector iopamidol, protamine, ethiodized oil reagent (viper)
09/15/2011WO2011112901A2 Hypermethylation biomarkers for detection of cervical cancer
09/15/2011WO2011112891A2 Plant defensive peptides
09/15/2011WO2011112890A1 Female-specific insect expression system
09/15/2011WO2011112880A2 Hypermethylation biomarkers for detection of head and neck squamous cell cancer
09/15/2011WO2011112570A1 Polynucleotide molecules for gene regulation in plants
09/15/2011WO2011112566A2 Basigin binding proteins
09/15/2011WO2011112549A2 Temperature sensitive conjugate compositions, and uses related thereto
09/15/2011WO2011112516A1 Treating and preventing hepatitis c virus infection using c-raf kinase antisense oligonucleotides
09/15/2011WO2011112380A2 Two novel alkylresorcinol synthase genes from sorghum; cloning, expression, transformation and characterization
09/15/2011WO2011112090A2 Method for identifying variant rep protein encoding nucleic acids
09/15/2011WO2011112089A2 Mutated rep encoding sequences for use in aav production
09/15/2011WO2011112057A2 Novel conditionally replication-competent adenovirus and a method for producing the same
09/15/2011WO2011112046A2 High molecular weight recombinant silk or silk-like protein, and micro- or nanoscale spider-web fiber or spider-web-like fiber produced using the recombinant silk or silk-like protein
09/15/2011WO2011111966A2 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses
09/15/2011WO2011111914A1 Vascular endothelial progenitor cells introduced with haptoglobin gene, and composition containing same for promoting angiogenesis
09/15/2011WO2011111874A1 Cell membrane-permeating dumbbell-type rna and method for producing the same
09/15/2011WO2011111841A1 Process for producing koda using lemna paucicostata
09/15/2011WO2011111838A1 Novel lipoxygenases derived from lemna paucicostata
09/15/2011WO2011111836A1 Mutated alkaline celluase
09/15/2011WO2011111832A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof
09/15/2011WO2011111829A1 Method for modifying rna binding protein using ppr motif
09/15/2011WO2011111820A1 Diagnostic marker for lung cancer or cervical cancer
09/15/2011WO2011111775A1 Method for extraction of free nucleic acid in blood
09/15/2011WO2011111715A1 Nucleic acid capable of regulating cell cycle
09/15/2011WO2011111698A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF
09/15/2011WO2011111694A1 Monoclonal antibody against necrosis marker prdx4 and use thereof
09/15/2011WO2011111638A1 Highly productive isopropyl alcohol-producing bacterium
09/15/2011WO2011111614A1 Method of selecting induced pluripotent stem cell
09/15/2011WO2011111595A1 Cell production method, cell, modified pc12 cell, gene, and mutant phosphoinositide-3kinase
09/15/2011WO2011111501A1 Rna containing nucleoside compound, method for controlling amount of protein production from that rna and nucleoside compound
09/15/2011WO2011111393A1 Fc binding protein and method for producing same
09/15/2011WO2011111392A1 Hjurp peptides and vaccines including the same
09/15/2011WO2011111072A2 Adeno-associated virus ezh2 shrna (aav ezh2 shrna)therapy for breast cancer
09/15/2011WO2011111060A1 A METHOD TO ENHANCE MULTIPLE ABIOTIC STRESS TOLERANCE OF CROP PLANTS BY OVER-EXPRESSION OF CYSTATHIONINE-β-SYNTHASE DOMAIN CONTAINING GENE AND CYSTATHIONINE-β-SYNTHASE DOMAIN CONTAINING GENE THEREFOR
09/15/2011WO2011111051A1 Death associated protein 1 variants and use thereof for modulating autophagy
09/15/2011WO2011111041A1 Organism with altered carotenoid content and method of producing same
09/15/2011WO2011111034A1 Recombinant protein production in heterologous systems
09/15/2011WO2011111020A1 Streptococcus thermophilus bacterium
09/15/2011WO2011110955A2 Methods of testing for intracellular pathogens
09/15/2011WO2011110864A1 Promoter sequence for dna and viral vectors
09/15/2011WO2011110713A1 Vector for the coexpression of a plurality of heterologous proteins in equimolar amounts
09/15/2011WO2011110683A2 Glce as a target for anti-tumour therapy
09/15/2011WO2011110621A1 Biological products: humanised agonistic anti-pd-1 antibodies
09/15/2011WO2011110610A1 Polypeptide having diterpene synthase activity
09/15/2011WO2011110604A1 Pd-1 antibody
09/15/2011WO2011110099A1 Enhanced plant-mediated rna interference in insects by utilizing cysteine protease
09/15/2011WO2011110051A1 Inductive production of pluripotent stem cells using synthetic transcription factors
09/15/2011WO2011109905A1 Modified family 5 cellulases and uses thereof
09/15/2011WO2011063324A3 Microfluidic systems for isolating microvesicles
09/15/2011WO2011061032A3 Cells, nucleic acids, enzymes, and use thereof, and methods for the production of sophorolipids
09/15/2011WO2011057710A3 Microorganisms having enhanced sucrose mutase activity
09/15/2011WO2011057248A3 Methods of propagating monkey adenoviral vectors
09/15/2011WO2011056886A3 Method and composition for generating programmed cell death resistant algal cells
09/15/2011WO2011053935A3 Enhanced gene expression in algae
09/15/2011WO2011053764A3 Methods for the biosynthesis of taurine or hypotaurine in cells
09/15/2011WO2011050431A3 Dna vaccine against virus of yellow fever
09/15/2011WO2011049409A9 Mannose 6-phosphate isomerase, mutants thereof, and use thereof
09/15/2011WO2011028041A3 Td probe and its uses
09/15/2011WO2011025310A3 Attenuated salmonella variant strain resulting from the genetic transformation of adhesin from pathogenic pig escherichia coli and a vaccine composition comprising the same for preventing and treating pathogenic colibacillosis and salmonellosis in pigs
09/15/2011WO2010104749A8 Antigen presenting cell targeted cancer vaccines
09/15/2011WO2007078280A8 Transgenic plants with enhanced agronomic traits
09/15/2011US20110225683 Importation of a Ribozyme into Vegetable Mitochondria by a Pseudo-tRNA that can be Aminoacylated by Valine
09/15/2011US20110225682 Polynucleotides encoding caryophyllene synthase and uses thereof
09/15/2011US20110225678 Rice promoters for regulation of plant expression
09/15/2011US20110225676 Two Novel Alkylresorcinol Synthase Genes from Sorghum; Cloning, Expression, Transformation and Characterization
09/15/2011US20110225675 Manipulation of ammonium transporters (amts) to improve nitrogen use efficiency in higher plants
09/15/2011US20110225674 Transformed plants or algae with highly expressed chloroplast protein BPG2